GenMark Diagnostics Return on Investment 2010-2019 | GNMK

Current and historical return on investment (ROI) values for GenMark Diagnostics (GNMK) over the last 10 years.
GenMark Diagnostics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-03-31 $-0.05B $0.07B -72.32%
2018-12-31 $-0.05B $0.07B -71.01%
2018-09-30 $-0.05B $0.07B -70.03%
2018-06-30 $-0.06B $0.06B -70.44%
2018-03-31 $-0.06B $0.08B -62.13%
2017-12-31 $-0.06B $0.09B -72.95%
2017-09-30 $-0.06B $0.09B -80.56%
2017-06-30 $-0.06B $0.11B -84.94%
2017-03-31 $-0.05B $0.04B -104.08%
2016-12-31 $-0.05B $0.05B -97.56%
2016-09-30 $-0.05B $0.06B -86.38%
2016-06-30 $-0.05B $0.05B -83.72%
2016-03-31 $-0.04B $0.05B -72.43%
2015-12-31 $-0.04B $0.06B -59.42%
2015-09-30 $-0.04B $0.06B -77.06%
2015-06-30 $-0.04B $0.07B -106.49%
2015-03-31 $-0.04B $0.08B -197.53%
2014-12-31 $-0.04B inf%
2014-09-30 $-0.04B inf%
2014-06-30 $-0.04B -142.37%
2014-03-31 $-0.04B -94.55%
2013-12-31 $-0.03B -62.10%
2013-09-30 $-0.03B $0.12B -42.03%
2013-06-30 $-0.02B $0.05B -42.20%
2013-03-31 $-0.02B $0.05B -35.44%
2012-12-31 $-0.02B $0.06B -42.11%
2012-09-30 $-0.02B $0.06B -48.09%
2012-06-30 $-0.02B $0.07B -55.00%
2012-03-31 $-0.02B $0.03B -64.23%
2011-12-31 $-0.02B $0.03B -75.00%
2011-09-30 $-0.03B $0.04B -119.59%
2011-06-30 $-0.03B $0.04B -186.67%
2011-03-31 $-0.03B $0.02B -635.29%
2010-12-31 $-0.02B inf%
2010-09-30 $-0.01B inf%
2010-06-30 $-0.01B inf%
2010-03-31 $0.00B nan%
2009-12-31 $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.358B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $114.795B 25.11
Intuitive Surgical (ISRG) United States $60.437B 55.69
Edwards Lifesciences (EW) United States $39.565B 39.53
IDEXX Laboratories (IDXX) United States $24.500B 64.27
Fresenius Medical Care AG KGaA (FMS) Germany $23.376B 15.36
Teleflex (TFX) United States $15.415B 33.40
Olympus (OCPNY) Japan $14.976B 112.05
SONOVA HOLDING (SONVY) Switzerland $14.611B 0.00
Sysmex ADR (SSMXY) Japan $14.124B 38.08
DexCom (DXCM) United States $13.436B 263.52
Hologic (HOLX) United States $12.689B 20.41
STERIS (STE) Ireland $12.500B 30.23
Varian Medical Systems (VAR) United States $12.264B 31.29
ABIOMED (ABMD) United States $11.776B 71.64
Masimo (MASI) United States $8.149B 49.93
Penumbra (PEN) United States $6.046B 255.96
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.013B 37.78
Integra LifeSciences Holdings (IART) United States $4.611B 21.66
Globus Medical (GMED) United States $4.211B 26.26
Tandem Diabetes Care (TNDM) United States $3.649B 0.00
LivaNova (LIVN) United Kingdom $3.575B 23.30
Wright Medical Group (WMGI) Netherlands $3.346B 663.25
Cantel Medical (CMD) United States $3.304B 33.52
Glaukos (GKOS) United States $2.794B 0.00
Integer Holdings (ITGR) United States $2.633B 19.40
Nihon Kohden (NHNKY) Japan $2.397B 24.11
AVANOS MEDICAL, INC (AVNS) United States $1.909B 30.21
Nevro (NVRO) United States $1.896B 0.00
Inogen (INGN) United States $1.313B 29.07
OPKO Health (OPK) United States $1.299B 0.00
Silk Road Medical (SILK) United States $1.262B 0.00
Veracyte (VCYT) United States $1.208B 0.00
CryoLife (CRY) United States $1.122B 111.33
Accelerate Diagnostics (AXDX) United States $1.039B 0.00
Tactile Systems Technology (TCMD) United States $1.019B 150.31
ORTHOFIX MEDICAL INC (OFIX) United States $0.975B 28.24
Mesa Laboratories (MLAB) United States $0.902B 42.40
Luminex (LMNX) United States $0.899B 117.53
Pacific Biosciences Of California (PACB) United States $0.896B 0.00
ViewRay (VRAY) United States $0.896B 0.00
Natus Medical (BABY) United States $0.877B 20.31
AngioDynamics (ANGO) United States $0.802B 26.27
AxoGen (AXGN) United States $0.787B 0.00
Fluidigm (FLDM) United States $0.780B 0.00
Quotient (QTNT) Switzerland $0.696B 0.00
Intersect ENT (XENT) United States $0.634B 0.00
Corindus Vascular Robotics (CVRS) United States $0.542B 0.00
OrthoPediatrics (KIDS) United States $0.531B 0.00
Si-Bone (SIBN) United States $0.493B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.344B 18.44
Accuray (ARAY) United States $0.320B 0.00
RTI Surgical (RTIX) United States $0.307B 37.82
Semler Scientific (SMLR) United States $0.304B 60.26
TransEnterix (TRXC) United States $0.296B 0.00
SeaSpine Holdings (SPNE) United States $0.240B 0.00
Neuronetics (STIM) United States $0.234B 0.00
Alphatec Holdings (ATEC) United States $0.220B 0.00
ConforMIS (CFMS) United States $0.216B 0.00
IRadimed (IRMD) United States $0.206B 39.19
CRH Medical (CRHM) Canada $0.201B 69.75
Sientra (SIEN) United States $0.184B 0.00
Stereotaxis (STXS) United States $0.170B 0.00
Second Sight Medical Products (EYES) United States $0.107B 0.00
Sensus Healthcare (SRTS) United States $0.089B 0.00
Ekso Bionics Holdings (EKSO) United States $0.086B 0.00
Vermillion (VRML) United States $0.082B 0.00
EDAP TMS S.A (EDAP) France $0.077B 0.00
T2 Biosystems (TTOO) United States $0.076B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.064B 0.00
Helius Medical Technologies (HSDT) United States $0.053B 0.00